| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |